Skip to Main content Skip to Navigation
Journal articles

Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres

Abstract : Radioembolization with (90)Y-loaded microspheres is increasingly used in the treatment of primary and secondary liver cancer. Technetium-99 m macroaggregated albumin (MAA) scintigraphy is used as a surrogate of microsphere distribution to assess lung or digestive shunting prior to therapy, based on tumoral targeting and dosimetry. To date, this has been the sole pre-therapeutic tool available for such evaluation. Several dosimetric approaches have been described using both glass and resin microspheres in hepatocellular carcinoma (HCC) and liver metastasis. Given that each product offers different specific activities and numbers of spheres injected, their radiobiological properties are believed to lightly differ. This paper summarizes and discusses the available studies focused on MAA-based dosimetry, particularly concentrating on potential confounding factors like clinical context, tumor size, cirrhosis, previous or concomitant therapy, and product used. In terms of the impact of tumoral dose in HCC, the results were concordant and a response relationship and tumoral threshold dose was clearly identified, especially in studies using glass microspheres. Tumoral dose has also been found to influence survival. The concept of treatment intensification has recently been introduced, yet despite several studies publishing interesting findings on the tumor dose-metastasis relationship, no consensus has been reached, and further clarification is thus required. Nor has the maximal tolerated dose to the liver been well documented, requiring more accurate evaluation. Lung dose was well described, despite recently identified factors influencing its evaluation, requiring further assessment. CONCLUSION: MAA SPECT/CT dosimetry is accurate in HCC and can now be used in order to achieve a fully customized approach, including treatment intensification. Yet further studies are warranted for the metastasis setting and evaluating the maximal tolerated liver dose
Document type :
Journal articles
Complete list of metadatas

Cited literature [56 references]  Display  Hide  Download
Contributor : Laurent Jonchère <>
Submitted on : Thursday, April 14, 2016 - 3:15:36 PM
Last modification on : Thursday, January 14, 2021 - 11:26:35 AM
Long-term archiving on: : Friday, July 15, 2016 - 1:00:16 PM


Clinical impact - version of r...
Publication funded by an institution


Distributed under a Creative Commons Attribution 4.0 International License



Etienne Garin, Yan Rolland, Sophie Laffont, Julien Edeline. Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres. European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2016, 43 (3), pp.559-575. ⟨10.1007/s00259-015-3157-8⟩. ⟨hal-01197349⟩



Record views


Files downloads